Anti-CD19 Monoclonal Antibody for Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder
May 2025
in “
The Journal of Rheumatology
”
Studysummary In this case report, two patients with coexisting systemic lupus erythematous and neuromyelitis optica spectrum disorder achieved remission of SLE activity using an anti-CD19 monoclonal antibody.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jrheum.org →